A pilot randomized clinical trial of two medication adherence and drug use interventions for HIV+ crack cocaine users

Drug and Alcohol Dependence

Volumn 116, Issue 1-3, 2011, Pages 177-187

  Ingersoll, Karen S ^a   Farrell Carnahan, Leah ^a   Cohen Filipic, Jessye ^b   Heckman, Carolyn J ^d   Ceperich, Sherry D ^c   Hettema, Jennifer ^a   Marzani Nissen, Gabrielle ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d FOX CHASE CANCER CENTER   (United States)

Author keywords

Adherence; Crack cocaine; HIV; Motivational Interviewing plus feedback; Video intervention

Indexed keywords

ANTIRETROVIRUS AGENT; COCAINE;

ADDICTION SEVERITY INDEX DRUG COMPOSITE SCORE; ADULT; AFRICAN AMERICAN; ARTICLE; BEHAVIOR MODIFICATION; COCAINE DEPENDENCE; CONTROLLED STUDY; EFFECT SIZE; FEASIBILITY STUDY; FEMALE; HETEROSEXUALITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MOTIVATIONAL INTERVIEWING PLUS FEEDBACK AND SKILLS BUILDING; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT COUNSELING; PATIENT SATISFACTION; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; VIDEO INFORMATION PLUS DEBRIEFING; VIRUS LOAD;

ADULT; ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BEHAVIOR THERAPY; COCAINE-RELATED DISORDERS; CRACK COCAINE; FEMALE; HIV; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; INTERVENTION STUDIES; INTERVIEW, PSYCHOLOGICAL; MALE; MEDICATION ADHERENCE; MOTIVATION; PATIENT COMPLIANCE; PILOT PROJECTS; TREATMENT OUTCOME; VIDEOTAPE RECORDING;

EID: 79957586481     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2010.12.016     Document Type: Article

References (60)

1. Amico K.R., Harman J.J., Johnson B.T. Efficacy of antiretroviral therapy adherence interventions: a research synthesis of trials, 1996 to 2004. J. Acquir. Immune Defic. Syndr. 2006, 41:285-297.
2. Amico K.R., Barta W., Konkle-Parker D.J., Fisher J.D., Cornman D.H., Shuper P.A., Fisher W.A. The information-motivation-behavioral skills model of ART adherence in a deep south HIV+ clinic sample. AIDS Behav. 2009, 13:66-75.
3. Arnsten J.H., Demas P.A., Grant R.W., Gourevitch M.N., Farzadegan H., Howard A.A., Schoenbaum E.E. Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. J. Gen. Intern. Med. 2002, 17:377-381.
4. Arnsten J.H., Demas P.A., Farzadegan H., Grant R.W., Gourevitch M.N., Chang C.J., Buono D., Eckholdt H., Howard A.A., Schoenbaum E.E. Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring. Clin. Infect. Dis. 2001, 33:1417-1423.
5. Bakeman R. Recommended effect size statistics for repeated measures designs. Behav. Res. Methods 2005, 37:379-384.
6. Bangsberg D.R., Acosta E.P., Gupta R., Guzman D., Riley E.D., Harrigan P.R., Parkin N., Deeks S.G. Adherence-resistance relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitness. AIDS 2006, 20:223-231.
7. Baum M.K., Rafie C., Lai S., Sales S., Page B., Campa A. Crack-cocaine use accelerates HIV disease progression in a cohort of HIV-positive drug users. J. Acquir. Immune Defic. Syndr. 2009, 50:93-99.
8. Brock T.P., Smith S.R. Using digital videos displayed on personal digital assistants (PDAs) to enhance patient education in clinical settings. Int. J. Med. Inform. 2007, 76:829-835.
9. Celentano D.D., Galai N., Sethi A.K., Shah N.G., Strathdee S.A., Vlahov D., Gallant J.E. Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users. AIDS 2001, 15:1707-1715.
10. Chiasson M.A., Shaw F.S., Humberstone M., Hirshfield S., Hartel D. Increased HIV disclosure three months after an online video intervention for men who have sex with men (MSM). AIDS Care 2009, 21:1081-1089.
11. Cohen, J., Ingersoll, K.S., 2005. Cocaine use interferes with HIV antiretroviral medication adherence: focus group results. Oral Presentation to the College on Problems of Drug Dependence Annual Scientific Meeting, Orlando, FL.
12. Cohen, J., Ingersoll, K.S., 2004. Identifying mental health issues and service needs of HIV+ Lesbians. Poster presented to the American Psychological Association convention, Honolulu, HI.
13. Cohen, J., Ingersoll, K.S., Fox, S., 2004. Service gaps reported by HIV+ cocaine users: focus group results. Poster presented to the American Psychological Association Convention, July, Honolulu, HI.
14. Cook J.A., Burke-Miller J.K., Cohen M.H., Cook R.L., Vlahov D., Wilson T.E., Golub E.T., Schwartz R.M., Howard A.A., Ponath C., Plankey M.W., Levine A.M., Grey D.D. Crack cocaine, disease progression, and mortality in a multicenter cohort of HIV-1 positive women. AIDS 2008, 22:1355-1363.
15. DeGerome A. Positively: Adults Coping with HIV and AIDS 2001, State of the Art, Inc., Washington, DC.
16. Fisher J.D., Amico K.R., Fisher W.A., Harman J.J. The information-motivation-behavioral skills model of antiretroviral adherence and its applications. Curr. HIV/AIDS Rep. 2008, 5:193-203.
17. Fisher J.D., Fisher W.A., Amico K.R., Harman J.J. An information-motivation-behavioral skills model of adherence to antiretroviral therapy. Health Psychol. 2006, 25:462-473.
18. Fogarty L., Roter D., Larson S., Burke J., Gillespie J., Levy R. Patient adherence to HIV medication regimens: a review of published and abstract reports. Patient Educ. Couns. 2002, 46:93-108.
19. Gilbert P., Ciccarone D., Gansky S.A., Bangsberg D.R., Clanon K., McPhee S.J., Calderon S.H., Bogetz A., Gerbert B. Interactive " video doctor" counseling reduces drug and sexual risk behaviors among HIV-positive patients in diverse outpatient settings. PLoS One 2008, 3:e1988.
20. Gold M.R., Siegel J.E., Russell L.B., Weinstein M.C. Cost-effectiveness in Health and Medicine 1996, Oxford University Press, New York.
21. Goldie S.J., Paltiel A.D., Weinstein M.C., Losina E., Seage G.R., Kimmel A.D., Walensky R.P., Sax P.E., Freedberg K.A. Projecting the cost-effectiveness of adherence interventions in persons with human immunodeficiency virus infection. Am. J. Med. 2003, 115:632-641.
22. Gross R., Bilker W.B., Wang H., Chapman J. How long is the window of opportunity between adherence failure and virologic failure on efavirenz-based HAART?. HIV Clin. Trials 2008, 9:202-206.
23. Harzke A.J., Williams M.L., Bowen A.M. Binge use of crack cocaine and sexual risk behaviors among African-American, HIV-positive users. AIDS Behav. 2009, 13:1106-1118.
24. Healton C.G., Messeri P. The effect of video interventions on improving knowledge and treatment compliance in the sexually transmitted disease clinic setting. Lesson for HIV health education. Sex Transm. Dis. 1993, 20:70-76.
25. Hettema, J., Ingersoll, K.S., unpublished data. Pilot study of prospective telephone adherence reporting and timeline followback adherence recall.
26. Holodniy, M., 2010. Ask the Experts About: Understanding Your Labs. The Body: The Complete HIV/AIDS Resource, (accessed 15.05.10.). http://www.thebody.com/Forums/AIDS/Labs/Archive/TestResults/.
27. Ickovics J.R., Meade C.S. Adherence to HAART among patients with HIV: breakthroughs and barriers. AIDS Care 2002, 14:309-318.
28. Ingersoll K. The impact of psychiatric symptoms, drug use, and medication regimen on non-adherence to HIV treatment. AIDS Care 2004, 16:199-211.
29. Kaiser Permanente Now That You Know: Living Healthy with HIV 1990, Concept Media, Irvine, CA.
30. Levin M., Casciato T., Hughes K., Pellett G., Wagner Mason P. Close to Home: Moyers on Addiction - Portrait of Addiction 1998, Films Media Group, Films for the Humanities and Sciences, New York, NY.
31. Lix L.M., Keselman H.J. Analysis of variance repeated measures designs. The Reviewer's Guide to Quantitative Methods in the Social Sciences 2010, 15-28. Routledge, New York, NY. G.R. Hancock, R.O. Mueller (Eds.).
32. Lucas G.M., Gebo K.A., Chaisson R.E., Moore R.D. Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic. AIDS 2002, 16:767-774.
33. Lucas G.M., Mullen B.A., McCaul M.E., Weidle P.J., Hader S., Moore R.D. Adherence, drug use, and treatment failure in a methadone-clinic-based program of directly administered antiretroviral therapy. AIDS Patient Care STDS 2007, 21:564-574.
34. Malta M., Strathdee S.A., Magnanini M.M., Bastos F.I. Adherence to antiretroviral therapy for human immunodeficiency virus/acquired immune deficiency syndrome among drug users: a systematic review. Addiction 2008, 103:1242-1257.
35. Malta M., Magnanini M.M., Strathdee S.A., Bastos F.I. Adherence to antiretroviral therapy among HIV-infected drug users: a meta-analysis. AIDS Behav. 2008, 14:731-747.
36. McGahan P.L., Griffith J.A., Parente R., McLellan A.T. Addiction Severity Index, Composite Score Manual 1986, The University of Pennsylvania/Veterans Administration Center for Studies of Addiction, Philadelphia.
37. McLellan A.T., Luborsky L., Cacciola J., Griffith J., Evans F., Barr H.L., O'Brien C.P. New data from the addiction severity index, reliability and validity in three centers. J. Nerv. Ment. Dis. 1985, 173:412-423.
38. Menendez-Arias L. Molecular basis of human immunodeficiency virus drug resistance: an update. Antiviral Res. 2010, 85:210-231.
39. Miller W.R., Rollnick S. Motivational Interviewing: Preparing People for Change 2002, Guilford Press, New York. 2nd edition.
40. Nieuwkerk P.T., Oort F.J. Self-reported adherence to antiretroviral therapy for HIV-1 infection and virologic treatment response: a meta-analysis. J. Acquir. Immune Defic. Syndr. 2005, 38:445-448.
41. Northwest AIDS Education and Training Center Taking Control: Adherence and HIV/AIDS Medication 1998, Northwest AIDS Education and Training Center, Seattle, WA.
42. Paredes R., Clotet B. Clinical management of HIV-1 resistance. Antiviral Res. 2010, 85:245-265.
43. Parsons J.T., Golub S.A., Rosof E., Holder C. Motivational interviewing and cognitive-behavioral intervention to improve HIV medication adherence among hazardous drinkers: a randomized controlled trial. J. Acquir. Immune Defic. Syndr. 2007, 46:443-450.
44. Purcell D.W., Latka M.H., Metsch L.R., Latkin C.A., Gomez C.A., Mizuno Y., Arnsten J.H., Wilkinson J.D., Knight K.R., Knowlton A.R., Santibanez S., Tobin K.E., Rose C.D., Valverde E.E., Gourevitch M.N., Eldred L., Borkowf C.B. Results from a randomized controlled trial of a peer-mentoring intervention to reduce HIV transmission and increase access to care and adherence to HIV medications among HIV-seropositive injection drug users. J. Acquir. Immune Defic. Syndr. 2007, 46:S35-S47. for the INSPIRE Study Team.
45. Rueda S., Park-Wyllie L.Y., Bayoumi A.M., Tynan A.M., Antoniou T.A., Rourke S.B., Glazier R.H. Patient support and education for promoting adherence to highly active antiretroviral therapy for HIV/AIDS. Cochrane Database Syst. Rev. 2006, 3:CD001442.
46. Samet J.H., Horton N.J., Meli S., Dukes K., Tripps T., Sullivan L., Freedberg K.A. A randomized controlled trial to enhance antiretroviral therapy adherence in patients with a history of alcohol problems. Antivir. Ther. 2005, 10:83-93.
47. Sampaio-Sa M., Page-Shafer K., Bangsberg D.R., Evans J., Dourado Mde L., Teixeira C., Netto E.M., Brites C. 100% adherence study: educational workshops vs. video sessions to improve adherence among ART-naive patients in Salvador. Brazil. AIDS Behav. 2008, 12:S54-S62.
48. Sandelowski M., Voils C.I., Chang Y., Lee E.J. A systematic review comparing antiretroviral adherence descriptive and intervention studies conducted in the USA. AIDS Care 2009, 21:953-966.
49. Sharpe T.T., Lee L.M., Nakashima A.K., Elam-Evans L.D., Fleming P.L. Crack cocaine use and adherence to antiretroviral treatment among HIV-infected black women. J. Community Health 2004, 29:117-127.
50. Sheehan D.V., Lecrubier Y., Harnett-Sheehan K., Janavs J., Weiller E., Bonora L.I., Keskiner A., Schinka J., Knapp E., Sheehan M.F., Dunbar G.C. Reliability and validity of the MINI international neuropsychiatric interview (M.I.N.I.): according to the SCID-P. Eur. Psychiatry 1997, 12:232-241.
51. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., Hergueta T., Baker R., Dunbar G.C. The mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry 1998, 59:22-33.
52. Simoni J.M., Frick P.A., Pantalone D.W., Turner B.J. Antiretroviral adherence interventions: a review of current literature and ongoing studies. Top. HIV Med. 2003, 11:185-198.
53. Simoni J.M., Pearson C.R., Pantalone D.W., Marks G., Crepaz N. Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load. A meta-analytic review of randomized controlled trials. J. Acquir. Immune Defic. Syndr. 2006, 43:S23-S35.
54. Sobell L.C., Sobell M.B. Timeline follow-back: a technique for assessing self-reported ethanol consumption. Measuring Alcohol Consumption: Psychosocial and Biological Methods 1992, 41-72. Humana Press, Totowa, NJ. R.Z. Litten, J. Allen (Eds.).
55. Tate D.F., Finkelstein E.A., Khavjou O., Gustafson A. Cost effectiveness of internet interventions: review and recommendations. Ann. Behav. Med. 2009, 48:40-45.
56. Tozzi V., Zaccarelli M., Bonfigli S., Lorenzini P., Liuzzi G., Trotta M.P., Forbici F., Gori C., Bertoli A., Bellagamba R., Narciso P., Perno C.F., Antinori A. Drug-class-wide resistance to antiretrovirals in HIV-infected patients failing therapy: prevalence, risk factors and virological outcome. Antivir. Ther. 2006, 11:553-560.
57. University of Washington High Impact: Substance Abuse and HIV Care 2000, Cascade Health, Seattle, WA.
58. Wang C., Vlahov D., Galai N., Bareta J., Strathdee S.A., Nelson K.E., Sterling T.R. Mortality in HIV-seropositive versus -seronegative persons in the era of highly active antiretroviral therapy: implications for when to initiate therapy. J. Infect. Dis. 2004, 190:1046-1054.
59. Wong I.Y., Lawrence N.V., Struthers H., McIntyre J., Friedland G.H. Development and assessment of an innovative culturally sensitive educational videotape to improve adherence to highly active antiretroviral therapy in Soweto, South Africa. J. Acquir. Immune Defic. Syndr. 2006, 43:S142-S148.
60. Zolopa A.R. The evolution of HIV treatment guidelines: current state-of-the-art of ART. Antiviral Res. 2010, 85:241-244.